Low Cholesterol Prevent Prostate Cancer
Men are able to keep his cholesterol low, can be protected from heart disease and prostate cancer.
Recent research study found that men who are in the range of healthy cholesterol - that is under 200 - have a lower risk of getting prostate cancer than men with high cholesterol.
While other studies have also found a man with a lot of HDL, or â¬Ëgood cholesterol', has no risk of prostate cancer than men with low HDL.
Both this research study is not definitive and it has some weaknesses. But researchers agree that many other disciplines that limit the fat in the blood stream can reduce the risk of cancer.
"There may be additional benefit is to maintain low cholesterol," said Elizabeth Platz of Johns Hopkins University.
Elizabeth Platz, doing research in 1990, against 5586 men aged 55 and older who are in a large placebo group. Cholesterol does not make a difference in the possibility of getting prostate cancer except for the 60 people who developed high-grade tumors, the type that grows and spreads quickly. Opportunity to develop one of these aggressive tumors have a total 59% lower among men with cholesterol under 200.
So far the researchers do not know how many men in this study using statin drugs like Lipitor, Zocor or CRESTOR. That means reducing the risk of some cancers can be derived from the cholesterol-lowering drugs, low-cholesterol rather than by itself.
Earlier reports also suggested that statins may reduce the risk of cancer, but it was too early to declare that the drug may reduce cancer risk. Statins have long been known to prevent heart disease, and no research on the new changes.
The second study involved more than 29,000 Finnish men. The men, all smokers, is testing whether the various vitamins and nutrients may reduce cancer risk.
"Those who have the highest levels of HDL as much as 11%, believed to be capable of developing prostate cancer compared with the lowest level," said study leader Dr. Demetrius Albanes of the National Cancer Institute.
Prostate cancer is the most common cancer in U.S. men. More than 192 000 new cases occurred in the U.S. this year, while the number of deaths from this disease as much as 27 360 deaths